Iravani S, Mao W, Fu L, Karl R, Yeatman T, Jove R, Coppola D
Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA.
Lab Invest. 1998 Mar;78(3):365-71.
The molecular events regulating the development and progression of colonic neoplasia are currently being delineated. Recent studies have implicated c-Src protein kinase activation as an early event in the malignant transformation of colonic epithelial cells. However, increased c-Src activity has also been reported in colon carcinomas as well as in metastatic hepatic and extrahepatic colon carcinomas. To further investigate the potential role of c-Src in the progression of colonic neoplasia, we analyzed c-Src levels by immunohistochemistry in 27 colorectal resection specimens. Mouse monoclonal antibody to c-Src protein was applied to 3-micron sections from formalin-fixed, paraffin-embedded tissues using the avidin-biotin-peroxidase method. The combination of adenomatous (AD) and adjacent carcinomatous mucosa (CA) specimens were present in 20 of 27 patients. In 15 cases, synchronous metastatic (MT) lesions were available for evaluation. Strong c-Src expression was evident in 95% of AD (n = 20), in contradistinction to 32% of MT (n = 19) and 14% of CA (n = 22). Weak-to-moderate c-Src expression was seen in adjacent normal colonic mucosa (NM) in 96% of cases. Signed rank test univariate analysis revealed a statistically significant difference in c-Src expression between NM/AD (p = 0.0001), NM/CA (p = 0.0001), NM/MT (p = 0.0006), AD/CA (p = 0.0001), and AD/MT (p = 0.0002). No significant correlation between levels of c-Src expression and patient survival, tumor size, histologic grade, or tumor configuration was observed using the Cox's Regression Model. Similar results were obtained by analysis of c-Src protein levels and c-Src kinase activity as measured by Western blot and in vitro kinase assays of representative cases. Our results indicate that: (a) elevated c-Src expression is an important early event during colorectal carcinogenesis; (b) its activation may be involved in tumor progression in a subset of colonic carcinomas; and (c) additional molecular events are necessary for invasion to occur.
目前正在阐明调节结肠肿瘤发生发展的分子事件。最近的研究表明,c-Src蛋白激酶激活是结肠上皮细胞恶性转化的早期事件。然而,在结肠癌以及转移性肝和肝外结肠癌中也报道了c-Src活性增加。为了进一步研究c-Src在结肠肿瘤进展中的潜在作用,我们通过免疫组织化学分析了27例结直肠切除标本中的c-Src水平。使用抗生物素蛋白-生物素-过氧化物酶方法,将针对c-Src蛋白的小鼠单克隆抗体应用于来自福尔马林固定、石蜡包埋组织的3微米切片。27例患者中有20例同时存在腺瘤(AD)和相邻癌性黏膜(CA)标本。在15例中,有同步转移(MT)病变可供评估。95%的AD(n = 20)中c-Src表达强烈,与之形成对比的是,MT(n = 19)中有32%,CA(n = 22)中有14%。96%的病例中,相邻正常结肠黏膜(NM)中可见弱至中度的c-Src表达。符号秩检验单变量分析显示,NM/AD(p = 0.0001)、NM/CA(p = 0.0001)、NM/MT(p = 0.0006)、AD/CA(p = 0.0001)和AD/MT(p = 0.0002)之间c-Src表达存在统计学显著差异。使用Cox回归模型未观察到c-Src表达水平与患者生存率、肿瘤大小、组织学分级或肿瘤形态之间存在显著相关性。通过对代表性病例进行蛋白质印迹分析和体外激酶测定来分析c-Src蛋白水平和c-Src激酶活性,也获得了类似结果。我们的结果表明:(a)c-Src表达升高是结直肠癌发生过程中的一个重要早期事件;(b)其激活可能参与了一部分结肠癌的肿瘤进展;(c)侵袭的发生还需要其他分子事件。